Literature DB >> 29768736

Change of signs, symptoms and voice quality evaluations throughout a 3- to 6-month empirical treatment for laryngopharyngeal reflux disease.

J R Lechien1,2,3, C Finck2,4, M Khalife3, K Huet2, V Delvaux2, M Picalugga2, B Harmegnies2, S Saussez1,3.   

Abstract

OBJECTIVE: To assess the usefulness of voice quality measurements as a treatment outcome in patients with laryngopharyngeal reflux (LPR)-related symptoms.
DESIGN: Prospective uncontrolled multi-centre study.
MATERIAL AND METHODS: A total of 80 clinically diagnosed LPR patients with a reflux finding score (RFS)>7 and a reflux symptom index (RSI)>13 were treated with pantoprazole and diet recommendations during 3 or 6 months, according to their evolution. RSI; RFS; blinded Grade, Roughness, Breathiness, Asthenia, Strain and Instability (GRBASI) and aerodynamic and acoustic measurements were evaluated at baseline, 3 months (n = 80), and 6 months (n = 41) post-treatment. We conducted a correlation analysis between the adherence to the diet, and the evolution of both signs and symptoms and between videolaryngostroboscopic signs and acoustic measurements.
RESULTS: Reflux symptom index, RFS, perceptual voice quality evaluations (dysphonia, roughness, strain and instability), and aerodynamic and acoustic measurements (ie, percent jitter and percent shimmer) were significantly improved at 3 months post-treatment but not at 6 months. Percent jitter was the most useful outcome for evaluating the clinical evolution of patients throughout the treatment course. A significant relationship between globus sensation and posterior commissure hypertrophy was documented; both seemed to significantly improve from 3 to 6 months. The correlation analysis revealed correlations between adherence to diet recommendations and the improvement of symptoms and between posterior commissure granulation severity and acoustic measurement impairments.
CONCLUSION: Voice quality improved in a manner similar to both signs and symptoms throughout a 6-month empirical treatment with better improvement the 3 first months. Voice quality assessments can be used as indicators of treatment effectiveness in patients with LPR-related symptoms.
© 2018 John Wiley & Sons Ltd.

Entities:  

Keywords:  laryngitis; laryngopharyngeal; reflux; voice

Mesh:

Substances:

Year:  2018        PMID: 29768736     DOI: 10.1111/coa.13140

Source DB:  PubMed          Journal:  Clin Otolaryngol        ISSN: 1749-4478            Impact factor:   2.597


  7 in total

1.  Association between laryngopharyngeal reflux disease and autonomic nerve dysfunction.

Authors:  A Min Wang; Gang Wang; Ning Huang; Yan Yan Zheng; Fan Yang; Xia Qiu; Xian Ming Chen
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-06-08       Impact factor: 2.503

2.  Acoustic measurements are useful therapeutic indicators of patients with dysphonia-related to reflux.

Authors:  Alexandra Rodriguez; Stéphane Hans; Jerome R Lechien; Sven Saussez; Géraldine Nowak; Lise Crevier-Buchman; Marta P Circiu
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-02-25       Impact factor: 2.503

3.  Best Practices in Treatment of Laryngopharyngeal Reflux Disease: A Multidisciplinary Modified Delphi Study.

Authors:  Afrin N Kamal; Shumon I Dhar; Thomas L Carroll; Lee M Akst; Jonathan M Bock; John O Clarke; Jerome R Lechien; Jacqueline Allen; Peter C Belafsky; Joel H Blumin; Walter W Chan; Ronnie Fass; P Marco Fisichella; Michael Marohn; Ashli K O'Rourke; Gregory Postma; Edoardo V Savarino; Michael F Vaezi
Journal:  Dig Dis Sci       Date:  2022-08-22       Impact factor: 3.487

4.  Transcutaneous electrical acupoint stimulation for suspected laryngopharyngeal reflux disease.

Authors:  Hailong Shen; Yanxun Han; Changyu Yao; Ye Tao; Jing Wu; Chaobing Gao; Feihu Wu; Yehai Liu
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-10-14       Impact factor: 3.236

5.  Magnesium alginate versus proton pump inhibitors for the treatment of laryngopharyngeal reflux: a non-inferiority randomized controlled trial.

Authors:  Nicole Pizzorni; Federico Ambrogi; Angelo Eplite; Sibora Rama; Carlo Robotti; Jerome Lechien; Antonio Schindler
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-01-15       Impact factor: 3.236

6.  Meta-analysis of Proton Pump Inhibitors in the Treatment of Pharyngeal Reflux Disease.

Authors:  Xiulin Jin; Xufeng Zhou; Zongxian Fan; Yingchun Qin; Junjie Zhan
Journal:  Comput Math Methods Med       Date:  2022-07-21       Impact factor: 2.809

7.  Treatment of laryngopharyngeal reflux disease: A systematic review.

Authors:  Jerome R Lechien; Francois Mouawad; Maria R Barillari; Andrea Nacci; Seyyedeh Maryam Khoddami; Necati Enver; Sampath Kumar Raghunandhan; Christian Calvo-Henriquez; Young-Gyu Eun; Sven Saussez
Journal:  World J Clin Cases       Date:  2019-10-06       Impact factor: 1.337

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.